- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Intestinal Lymphomas in New Zealand
Total 3556 results
-
Aprea TherapeuticsTerminatedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States
-
Jennifer AmengualCompletedLymphoma | Multiple Myeloma | Hodgkin Lymphoma | Lymphoid Malignancies | Non-hodgkin LymphomaUnited States
-
Helsinn Therapeutics (U.S.), IncCompleted
-
GlaxoSmithKlineTerminatedNeoplasms | CancerUnited States, United Kingdom, France
-
Peter MacCallum Cancer Centre, AustraliaAbbVieNot yet recruitingRelapsed/Refractory Large B-cell LymphomaAustralia
-
Dana-Farber Cancer InstitutePfizerActive, not recruiting
-
National Cancer Institute (NCI)RecruitingNodular Lymphocyte Predominant B-Cell Lymphoma | Recurrent Nodular Lymphocyte Predominant B-Cell Lymphoma | Refractory Nodular Lymphocyte Predominant B-Cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedClassic Hodgkin Lymphoma | Lugano Classification Stage III Hodgkin Lymphoma AJCC v8 | Lugano Classification Stage IV Hodgkin Lymphoma AJCC v8United States
-
UCB CelltechTerminatedCrohn's DiseaseUnited States, Canada, New Zealand, Australia
-
Janssen Research & Development, LLCPharmacyclics LLC.CompletedCD20-positive B-cell Non-Hodgkin LymphomaUnited States, France
-
Acerta Pharma BVActive, not recruitingActivated B-cell Diffuse Large B-Cell Lymphoma (ABC DLBCL)United States, United Kingdom
-
Curis, Inc.The Leukemia and Lymphoma SocietyCompletedLymphoma | Refractory Lymphoma | Relapsed Lymphoma | Relapsed and/or Refractory Lymphoma | Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL) | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Double-hit Lymphoma (DHL) | Triple-hit Lymphoma... and other conditionsUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); University of Medicine and Dentistry of New...Active, not recruitingColorectal Cancer | Metastatic CancerUnited States
-
Eisai Inc.National Cancer Institute (NCI); Tufts Medical Center; Ligand PharmaceuticalsCompleted
-
Acerta Pharma BVAstraZenecaActive, not recruitingNon Hodgkin LymphomaUnited States, Canada, Italy
-
Beth Israel Deaconess Medical CenterTerminated
-
Acrotech Biopharma Inc.CompletedPeripheral T-cell LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin LymphomaUnited States
-
Spectrum Pharmaceuticals, IncCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
National Cancer Institute (NCI)CompletedLymphomaUnited States, Australia, South Africa, Peru, Puerto Rico
-
University of Michigan Rogel Cancer CenterBristol-Myers Squibb; Bayer; University of Michigan; Big Ten Cancer Research ConsortiumActive, not recruiting
-
Montefiore Medical CenterNational Cancer Institute (NCI)Completed
-
Weill Medical College of Cornell UniversityCompletedHodgkins Disease | Lymphoma, Non-HodgkinsUnited States
-
BioCryst PharmaceuticalsCompletedCutaneous T-cell Lymphoma (CTCL),United States, Australia, Germany, Italy, Spain, France, Austria, Finland, Switzerland, United Kingdom
-
gicare Pharma Inc.Algorithme Pharma Inc; JSS Medical Research Inc.CompletedPain | Cancer | Colonic DiseasesUnited States, Canada
-
Seagen Inc.Genentech, Inc.Completed
-
Kymera Therapeutics, Inc.SuspendedNon Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | DLBCL | MYD88 Gene MutationUnited States, United Kingdom
-
Jazz PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Lymphoblastic LymphomaUnited States, Canada
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbActive, not recruitingPrimary Central Nervous System Lymphoma (PCNSL)United States
-
MEI Pharma, Inc.Kyowa Kirin, Inc.TerminatedPhase 3 Study of Zandelisib (ME-401) in Combination With Rituximab in Patients With iNHL - (COASTAL)Marginal Zone Lymphoma | Non Hodgkin Lymphoma | Follicular Lymphoma (FL)United States, France, Spain, Korea, Republic of, United Kingdom, Belgium, Japan, Taiwan, Australia, Poland, Italy, Canada, Georgia, Greece, Hungary, Netherlands, New Zealand, Serbia, Turkey
-
Memorial Sloan Kettering Cancer CenterCompletedRectal CancerUnited States
-
Millennium Pharmaceuticals, Inc.CompletedRelapsed Follicular LymphomaUnited States, Puerto Rico
-
Weill Medical College of Cornell UniversityMillennium Pharmaceuticals, Inc.CompletedNon-Hodgkin's LymphomaUnited States
-
National Center for Complementary and Integrative...Completed
-
Janssen Research & Development, LLCTerminatedLymphoma, Follicular | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Mantle-CellUnited States, Australia, France, Belgium, Turkey, Netherlands, Korea, Republic of
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedNon-Hodgkin's Lymphoma | Lung CancerUnited States
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited States, United Kingdom
-
Icahn School of Medicine at Mount SinaiNational Cancer Institute (NCI)Completed
-
Denovo Biopharma LLCCompletedDiffuse Large B-Cell LymphomaUnited States, China
-
Columbia UniversityCompletedNon-Hodgkin's Lymphoma | Hodgkins DiseaseUnited States
-
Alliance Foundation Trials, LLC.PfizerActive, not recruitingB Cell Lymphoma | Mantle Cell LymphomaUnited States
-
Criterium, Inc.AmgenActive, not recruitingColorectal Cancer MetastaticUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingMycosis Fungoides | Sezary Syndrome | Mycosis Fungoides/Sezary Syndrome | Sézary | Advanced Mycosis FungoidesUnited States
-
Mustang BioNational Cancer Institute (NCI)RecruitingMantle Cell Lymphoma Recurrent | Mantle Cell Lymphoma Refractory | Small Lymphocytic Lymphoma, Relapsed | Waldenstrom's Macroglobulinemia Recurrent | Follicular B-cell Non-Hodgkin's Lymphoma | B-cell Lymphoma Refractory | Waldenstrom's Macroglobulinemia Refractory | Chronic Lymphoid Leukemia in RelapseUnited States
-
Seagen Inc.RecruitingLymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Hodgkin Disease | Lymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, Peripheral | Lymphoma, Large-Cell, AnaplasticUnited States, Spain
-
Acrotech Biopharma Inc.CompletedB-cell Lymphoma | Hodgkin's Lymphoma | Relapsed or Refractory Lymphoproliferative Malignancies | Peripheral T-cell Lymphoma | Waldenstrom's MacroglobulinemiaUnited States
-
Northwell HealthNew York Blood CenterCompletedHodgkin Lymphoma | Acute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Acute Myelogenous Leukemia | Chronic Myelogenous LeukemiaUnited States
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
Rutgers, The State University of New JerseyCompletedPostoperative Complications | Postoperative Nausea and Vomiting | Postoperative Care | Intestinal Pseudo-Obstruction | Osteopathic Medicine | Manipulation, OsteopathicUnited States
-
Brown UniversityThe Miriam Hospital; Dartmouth-Hitchcock Medical Center; Rhode Island Hospital; Memorial Hospital of Rhode IslandTerminatedLymphoma, Non-HodgkinsUnited States